

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | purine deoxyribonucleotide catabolic process (GO:0009155) | 7.12094456 |
| 2 | negative regulation of B cell apoptotic process (GO:0002903) | 6.85676858 |
| 3 | positive regulation of megakaryocyte differentiation (GO:0045654) | 5.54065076 |
| 4 | deoxyribonucleotide catabolic process (GO:0009264) | 5.34982934 |
| 5 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 5.32641219 |
| 6 | deoxyribose phosphate catabolic process (GO:0046386) | 4.97914840 |
| 7 | regulation of B cell apoptotic process (GO:0002902) | 4.83603686 |
| 8 | purine nucleotide salvage (GO:0032261) | 4.71428631 |
| 9 | negative regulation of phagocytosis (GO:0050765) | 4.66001907 |
| 10 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.58253553 |
| 11 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.58253553 |
| 12 | regulation of chemokine biosynthetic process (GO:0045073) | 4.54073939 |
| 13 | positive regulation of prostaglandin secretion (GO:0032308) | 4.36947196 |
| 14 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 4.33748292 |
| 15 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.30076370 |
| 16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.30042088 |
| 17 | purine deoxyribonucleotide metabolic process (GO:0009151) | 4.24243822 |
| 18 | regulation of growth of symbiont in host (GO:0044126) | 4.15422804 |
| 19 | negative regulation of growth of symbiont in host (GO:0044130) | 4.15422804 |
| 20 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.15422804 |
| 21 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.15422804 |
| 22 | neutrophil mediated immunity (GO:0002446) | 4.02800161 |
| 23 | post-embryonic morphogenesis (GO:0009886) | 3.94756541 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.92686057 |
| 25 | regulation of gene silencing by RNA (GO:0060966) | 3.88599264 |
| 26 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.88599264 |
| 27 | regulation of gene silencing by miRNA (GO:0060964) | 3.88599264 |
| 28 | histone H3-K9 methylation (GO:0051567) | 3.86853181 |
| 29 | histone H3-K9 modification (GO:0061647) | 3.81883840 |
| 30 | nucleotide salvage (GO:0043173) | 3.80820474 |
| 31 | grooming behavior (GO:0007625) | 3.78552845 |
| 32 | base-excision repair, AP site formation (GO:0006285) | 3.75245229 |
| 33 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.74832247 |
| 34 | snRNA processing (GO:0016180) | 3.69053731 |
| 35 | definitive hemopoiesis (GO:0060216) | 3.67349079 |
| 36 | regulation of prostaglandin secretion (GO:0032306) | 3.63984900 |
| 37 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.63233344 |
| 38 | negative regulation of gene silencing (GO:0060969) | 3.58085175 |
| 39 | aggressive behavior (GO:0002118) | 3.53683893 |
| 40 | imidazole-containing compound metabolic process (GO:0052803) | 3.52727098 |
| 41 | snRNA metabolic process (GO:0016073) | 3.49806446 |
| 42 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.46344286 |
| 43 | negative regulation of interleukin-8 production (GO:0032717) | 3.43707217 |
| 44 | cellular response to interferon-beta (GO:0035458) | 3.37167942 |
| 45 | DNA deamination (GO:0045006) | 3.34056745 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33808609 |
| 47 | deoxyribonucleotide metabolic process (GO:0009262) | 3.29945645 |
| 48 | deoxyribose phosphate metabolic process (GO:0019692) | 3.27247996 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18333138 |
| 50 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.17120554 |
| 51 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.17051013 |
| 52 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.16168087 |
| 53 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14720973 |
| 54 | Peyers patch development (GO:0048541) | 3.09386750 |
| 55 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.09386750 |
| 56 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.08262856 |
| 57 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.06826166 |
| 58 | regulation of megakaryocyte differentiation (GO:0045652) | 3.05996437 |
| 59 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.00383465 |
| 60 | purine nucleobase biosynthetic process (GO:0009113) | 2.98545536 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 2.95518304 |
| 62 | negative regulation of chemokine production (GO:0032682) | 2.95289958 |
| 63 | mannosylation (GO:0097502) | 2.92224398 |
| 64 | estrogen biosynthetic process (GO:0006703) | 2.91238594 |
| 65 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.91135624 |
| 66 | immunoglobulin mediated immune response (GO:0016064) | 2.89108480 |
| 67 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.88143526 |
| 68 | DNA dealkylation (GO:0035510) | 2.87950349 |
| 69 | purine-containing compound salvage (GO:0043101) | 2.87852648 |
| 70 | mitochondrial DNA replication (GO:0006264) | 2.87605084 |
| 71 | mature B cell differentiation involved in immune response (GO:0002313) | 2.86202924 |
| 72 | cellular extravasation (GO:0045123) | 2.83193530 |
| 73 | myeloid leukocyte mediated immunity (GO:0002444) | 2.77573459 |
| 74 | DNA topological change (GO:0006265) | 2.75514599 |
| 75 | reactive oxygen species biosynthetic process (GO:1903409) | 2.74496916 |
| 76 | GDP-mannose metabolic process (GO:0019673) | 2.74195465 |
| 77 | negative regulation of mRNA processing (GO:0050686) | 2.73677486 |
| 78 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.73291397 |
| 79 | regulation of penile erection (GO:0060405) | 2.72847245 |
| 80 | cellular response to exogenous dsRNA (GO:0071360) | 2.72516133 |
| 81 | regulation of translational fidelity (GO:0006450) | 2.72013806 |
| 82 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.71013992 |
| 83 | hyperosmotic salinity response (GO:0042538) | 2.70008173 |
| 84 | purine nucleoside diphosphate metabolic process (GO:0009135) | 2.69744119 |
| 85 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 2.69744119 |
| 86 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.68659917 |
| 87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67470633 |
| 88 | ribosomal small subunit assembly (GO:0000028) | 2.66855427 |
| 89 | prostanoid biosynthetic process (GO:0046457) | 2.65836261 |
| 90 | prostaglandin biosynthetic process (GO:0001516) | 2.65836261 |
| 91 | respiratory burst (GO:0045730) | 2.65794860 |
| 92 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.65262301 |
| 93 | cell wall macromolecule catabolic process (GO:0016998) | 2.64877620 |
| 94 | blood vessel maturation (GO:0001955) | 2.63800247 |
| 95 | nucleobase biosynthetic process (GO:0046112) | 2.63774255 |
| 96 | nucleoside diphosphate catabolic process (GO:0009134) | 2.61333670 |
| 97 | regulation of antigen processing and presentation (GO:0002577) | 2.61245011 |
| 98 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.60983195 |
| 99 | DNA ligation (GO:0006266) | 2.60515453 |
| 100 | positive regulation of icosanoid secretion (GO:0032305) | 2.59977202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.92119813 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.81246319 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.78666935 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.75687302 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.69542624 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.60116967 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46480036 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.42061389 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31816172 |
| 10 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.28473332 |
| 11 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.13878363 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13820796 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.13095782 |
| 14 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10502995 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.03891405 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01544524 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.00584858 |
| 18 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.98951826 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97280004 |
| 20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.96517201 |
| 21 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91012561 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88278641 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.85065281 |
| 24 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.84804249 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.82618691 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.79534750 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77707836 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.77413251 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75071913 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72398585 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71731161 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.71369581 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71128419 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.70954834 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.64562623 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64191028 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63822851 |
| 38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60319426 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.59547723 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.59174325 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.58009396 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.56252673 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53506487 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.50441929 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.50172190 |
| 46 | MYB_26560356_Chip-Seq_TH2_Human | 1.49894500 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.49740974 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49304230 |
| 49 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48130867 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46606290 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46249587 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44446506 |
| 53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.44198858 |
| 54 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.42580614 |
| 55 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.41422379 |
| 56 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.40444973 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.39174424 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.38894279 |
| 59 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37909384 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.33041088 |
| 61 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.32907453 |
| 62 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32476409 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32472070 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.31104607 |
| 65 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.30421228 |
| 66 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.30223204 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29007411 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28683550 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28506903 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.28007888 |
| 71 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.27690312 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26067185 |
| 73 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.25061232 |
| 74 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.24385933 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23068011 |
| 76 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22420990 |
| 77 | P300_27268052_Chip-Seq_Bcells_Human | 1.21413875 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.21164674 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21148293 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20669527 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19669534 |
| 82 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19153142 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18102603 |
| 84 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.17936042 |
| 85 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.17678183 |
| 86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17631494 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16409104 |
| 88 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.16304969 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16122816 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16029047 |
| 91 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15423175 |
| 92 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12366373 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12203100 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12139793 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11744844 |
| 96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10919060 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09519907 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08823200 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07836073 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.07809714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001545_abnormal_hematopoietic_system | 3.69567344 |
| 2 | MP0005397_hematopoietic_system_phenotyp | 3.69567344 |
| 3 | MP0009278_abnormal_bone_marrow | 3.50548044 |
| 4 | MP0000465_gastrointestinal_hemorrhage | 2.96431373 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.78984872 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.71586870 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.68486163 |
| 8 | MP0008058_abnormal_DNA_repair | 2.62201175 |
| 9 | MP0001764_abnormal_homeostasis | 2.53812849 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.38490452 |
| 11 | MP0005387_immune_system_phenotype | 2.29877829 |
| 12 | MP0001790_abnormal_immune_system | 2.29877829 |
| 13 | MP0004808_abnormal_hematopoietic_stem | 2.16297923 |
| 14 | MP0005025_abnormal_response_to | 2.14563088 |
| 15 | MP0004043_abnormal_pH_regulation | 2.08998673 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.08579206 |
| 17 | MP0004133_heterotaxia | 2.01236552 |
| 18 | MP0005464_abnormal_platelet_physiology | 1.96386088 |
| 19 | MP0008057_abnormal_DNA_replication | 1.89323825 |
| 20 | MP0002419_abnormal_innate_immunity | 1.78679137 |
| 21 | MP0001800_abnormal_humoral_immune | 1.78619654 |
| 22 | MP0010094_abnormal_chromosome_stability | 1.78410723 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.74520021 |
| 24 | MP0006072_abnormal_retinal_apoptosis | 1.69186689 |
| 25 | MP0004782_abnormal_surfactant_physiolog | 1.67555722 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.66858648 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.62120375 |
| 28 | MP0002398_abnormal_bone_marrow | 1.62038759 |
| 29 | MP0005645_abnormal_hypothalamus_physiol | 1.60841083 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.59868578 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.59867608 |
| 32 | MP0001819_abnormal_immune_cell | 1.58967001 |
| 33 | MP0008007_abnormal_cellular_replicative | 1.57639941 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.53498544 |
| 35 | MP0003436_decreased_susceptibility_to | 1.51031469 |
| 36 | MP0003866_abnormal_defecation | 1.48953152 |
| 37 | MP0004147_increased_porphyrin_level | 1.48732053 |
| 38 | MP0002723_abnormal_immune_serum | 1.47287769 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.45946628 |
| 40 | MP0001873_stomach_inflammation | 1.45039589 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.44864967 |
| 42 | MP0005671_abnormal_response_to | 1.43636540 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.42240084 |
| 44 | MP0000681_abnormal_thyroid_gland | 1.41826189 |
| 45 | MP0000716_abnormal_immune_system | 1.41812246 |
| 46 | MP0002722_abnormal_immune_system | 1.41677876 |
| 47 | MP0009785_altered_susceptibility_to | 1.39911214 |
| 48 | MP0002019_abnormal_tumor_incidence | 1.39095097 |
| 49 | MP0005000_abnormal_immune_tolerance | 1.32536487 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.32428321 |
| 51 | MP0002822_catalepsy | 1.31611947 |
| 52 | MP0002429_abnormal_blood_cell | 1.30540064 |
| 53 | MP0003786_premature_aging | 1.29515136 |
| 54 | MP0003787_abnormal_imprinting | 1.23855124 |
| 55 | MP0000685_abnormal_immune_system | 1.23582794 |
| 56 | MP0005670_abnormal_white_adipose | 1.23029021 |
| 57 | MP0002405_respiratory_system_inflammati | 1.22459181 |
| 58 | MP0008995_early_reproductive_senescence | 1.20910589 |
| 59 | MP0005310_abnormal_salivary_gland | 1.16961717 |
| 60 | MP0010386_abnormal_urinary_bladder | 1.16823629 |
| 61 | MP0002095_abnormal_skin_pigmentation | 1.16391380 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.14134137 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 1.11305639 |
| 64 | MP0005501_abnormal_skin_physiology | 1.11080977 |
| 65 | MP0005367_renal/urinary_system_phenotyp | 1.08843204 |
| 66 | MP0000516_abnormal_urinary_system | 1.08843204 |
| 67 | MP0009764_decreased_sensitivity_to | 1.08418020 |
| 68 | MP0008469_abnormal_protein_level | 1.07743895 |
| 69 | MP0000490_abnormal_crypts_of | 1.05696492 |
| 70 | MP0003111_abnormal_nucleus_morphology | 1.05573723 |
| 71 | MP0003077_abnormal_cell_cycle | 1.04044279 |
| 72 | MP0005266_abnormal_metabolism | 1.04032355 |
| 73 | MP0003718_maternal_effect | 1.02897964 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 1.00072509 |
| 75 | MP0000372_irregular_coat_pigmentation | 0.99375904 |
| 76 | MP0008873_increased_physiological_sensi | 0.97749140 |
| 77 | MP0005666_abnormal_adipose_tissue | 0.97077885 |
| 78 | MP0005410_abnormal_fertilization | 0.95309349 |
| 79 | MP0005647_abnormal_sex_gland | 0.93573056 |
| 80 | MP0002971_abnormal_brown_adipose | 0.92344043 |
| 81 | MP0005334_abnormal_fat_pad | 0.88615393 |
| 82 | MP0000015_abnormal_ear_pigmentation | 0.88134118 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.86396656 |
| 84 | MP0001845_abnormal_inflammatory_respons | 0.83888774 |
| 85 | MP0002928_abnormal_bile_duct | 0.81588489 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 0.80890658 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.80724867 |
| 88 | MP0003943_abnormal_hepatobiliary_system | 0.80376502 |
| 89 | MP0001661_extended_life_span | 0.79781930 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 0.79572537 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.75222068 |
| 92 | MP0009115_abnormal_fat_cell | 0.75169066 |
| 93 | MP0000598_abnormal_liver_morphology | 0.74621547 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.73083716 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.72565161 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.72319088 |
| 97 | MP0003385_abnormal_body_wall | 0.69546324 |
| 98 | MP0002970_abnormal_white_adipose | 0.66270359 |
| 99 | MP0009763_increased_sensitivity_to | 0.65222419 |
| 100 | MP0000858_altered_metastatic_potential | 0.62697612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.97948579 |
| 2 | Thrombocytosis (HP:0001894) | 6.42583891 |
| 3 | Progressive external ophthalmoplegia (HP:0000590) | 5.23689258 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.91261831 |
| 5 | Cellulitis (HP:0100658) | 4.50237690 |
| 6 | Tubulointerstitial nephritis (HP:0001970) | 4.35998767 |
| 7 | Abnormality of the prostate (HP:0008775) | 4.20728560 |
| 8 | Congenital stationary night blindness (HP:0007642) | 3.52435497 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.45016818 |
| 10 | Progressive muscle weakness (HP:0003323) | 3.40361694 |
| 11 | Obstructive lung disease (HP:0006536) | 3.29157526 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29157526 |
| 13 | Glucose intolerance (HP:0000833) | 3.22788291 |
| 14 | Meningitis (HP:0001287) | 3.15751890 |
| 15 | Abnormality of B cell number (HP:0010975) | 3.11151917 |
| 16 | Neutropenia (HP:0001875) | 3.00182615 |
| 17 | Sepsis (HP:0100806) | 2.99782783 |
| 18 | Ureteral stenosis (HP:0000071) | 2.98980660 |
| 19 | Chromsome breakage (HP:0040012) | 2.98824314 |
| 20 | Eosinophilia (HP:0001880) | 2.98446114 |
| 21 | Reticulocytopenia (HP:0001896) | 2.96493564 |
| 22 | Granulocytopenia (HP:0001913) | 2.93044943 |
| 23 | Failure to thrive in infancy (HP:0001531) | 2.88825229 |
| 24 | Acute lymphatic leukemia (HP:0006721) | 2.88153593 |
| 25 | Hyperglycinemia (HP:0002154) | 2.84032083 |
| 26 | Hepatocellular necrosis (HP:0001404) | 2.83133957 |
| 27 | B lymphocytopenia (HP:0010976) | 2.80088555 |
| 28 | Ragged-red muscle fibers (HP:0003200) | 2.79325813 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 2.76541138 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76541138 |
| 31 | Rhabdomyolysis (HP:0003201) | 2.75381162 |
| 32 | Type I transferrin isoform profile (HP:0003642) | 2.72251216 |
| 33 | Ureteral obstruction (HP:0006000) | 2.67488000 |
| 34 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.67485691 |
| 35 | Abnormal protein glycosylation (HP:0012346) | 2.66058793 |
| 36 | Abnormal glycosylation (HP:0012345) | 2.66058793 |
| 37 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.66058793 |
| 38 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.66058793 |
| 39 | Chest pain (HP:0100749) | 2.64589709 |
| 40 | Abnormality of male internal genitalia (HP:0000022) | 2.63861904 |
| 41 | Leukocytosis (HP:0001974) | 2.61929261 |
| 42 | Thoracic kyphosis (HP:0002942) | 2.61751027 |
| 43 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.58903188 |
| 44 | Recurrent pneumonia (HP:0006532) | 2.57378286 |
| 45 | Abnormality of the thoracic spine (HP:0100711) | 2.56253170 |
| 46 | External ophthalmoplegia (HP:0000544) | 2.55204573 |
| 47 | Periodontitis (HP:0000704) | 2.54777992 |
| 48 | Skin rash (HP:0000988) | 2.54212966 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.50894238 |
| 50 | Verrucae (HP:0200043) | 2.48857213 |
| 51 | Papilloma (HP:0012740) | 2.48857213 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.47224024 |
| 53 | Duplication of thumb phalanx (HP:0009942) | 2.45061375 |
| 54 | Episodic fever (HP:0001954) | 2.41532825 |
| 55 | Hepatic necrosis (HP:0002605) | 2.40212387 |
| 56 | Chronic sinusitis (HP:0011109) | 2.40210443 |
| 57 | Prostate neoplasm (HP:0100787) | 2.40157159 |
| 58 | Cerebral palsy (HP:0100021) | 2.39300559 |
| 59 | Hypergonadotropic hypogonadism (HP:0000815) | 2.39249426 |
| 60 | Loss of speech (HP:0002371) | 2.39067603 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.37426893 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.37415464 |
| 63 | Myositis (HP:0100614) | 2.31933136 |
| 64 | Supernumerary spleens (HP:0009799) | 2.31695636 |
| 65 | Abnormality of the pleura (HP:0002103) | 2.27359190 |
| 66 | Hydroureter (HP:0000072) | 2.23507570 |
| 67 | Short tibia (HP:0005736) | 2.21926034 |
| 68 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21392163 |
| 69 | Muscle stiffness (HP:0003552) | 2.21233572 |
| 70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21132913 |
| 71 | Prolonged neonatal jaundice (HP:0006579) | 2.08854913 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.08393110 |
| 73 | Testicular atrophy (HP:0000029) | 2.05868549 |
| 74 | Volvulus (HP:0002580) | 2.04248089 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03545380 |
| 76 | Severe visual impairment (HP:0001141) | 2.03075728 |
| 77 | Dehydration (HP:0001944) | 1.99558426 |
| 78 | Progressive microcephaly (HP:0000253) | 1.99094935 |
| 79 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.98630722 |
| 80 | Persistence of primary teeth (HP:0006335) | 1.95759855 |
| 81 | Abnormal glucose tolerance (HP:0001952) | 1.94994088 |
| 82 | Recurrent viral infections (HP:0004429) | 1.91802581 |
| 83 | Hypoplasia of the pons (HP:0012110) | 1.89772437 |
| 84 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.89769811 |
| 85 | Cerebellar dysplasia (HP:0007033) | 1.85836105 |
| 86 | Hypergammaglobulinemia (HP:0010702) | 1.85635017 |
| 87 | Impulsivity (HP:0100710) | 1.85050808 |
| 88 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82891865 |
| 89 | Asplenia (HP:0001746) | 1.81949944 |
| 90 | Thyroid-stimulating hormone excess (HP:0002925) | 1.80950515 |
| 91 | Villous atrophy (HP:0011473) | 1.80893992 |
| 92 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80893992 |
| 93 | Enlarged kidneys (HP:0000105) | 1.78889901 |
| 94 | Mediastinal lymphadenopathy (HP:0100721) | 1.76102357 |
| 95 | Emotional lability (HP:0000712) | 1.75501220 |
| 96 | Osteomyelitis (HP:0002754) | 1.73284467 |
| 97 | Large eyes (HP:0001090) | 1.73067425 |
| 98 | Petechiae (HP:0000967) | 1.71672516 |
| 99 | Vasculitis (HP:0002633) | 1.70568050 |
| 100 | Nephronophthisis (HP:0000090) | 1.70553171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 9.60548939 |
| 2 | ERN1 | 5.20259715 |
| 3 | TNK2 | 3.16088256 |
| 4 | PIM2 | 2.83597150 |
| 5 | BCKDK | 2.59476523 |
| 6 | KDR | 2.48542954 |
| 7 | ARAF | 2.43521661 |
| 8 | GRK1 | 2.35067683 |
| 9 | VRK2 | 2.34057509 |
| 10 | MAP4K2 | 2.33313847 |
| 11 | PBK | 2.19589613 |
| 12 | TRIM28 | 2.13864154 |
| 13 | MAP3K13 | 1.84509556 |
| 14 | SIK2 | 1.72787403 |
| 15 | SIK3 | 1.63402697 |
| 16 | PRKD2 | 1.63107234 |
| 17 | MAP4K1 | 1.46657772 |
| 18 | ZAK | 1.45000397 |
| 19 | CDK12 | 1.44743111 |
| 20 | KIT | 1.26651070 |
| 21 | SIK1 | 1.18941914 |
| 22 | CCNB1 | 1.10916959 |
| 23 | TAOK3 | 1.10189936 |
| 24 | FLT3 | 1.08748624 |
| 25 | CDK6 | 1.05190406 |
| 26 | TYK2 | 1.03067866 |
| 27 | MARK3 | 1.03065900 |
| 28 | CHEK2 | 0.97545274 |
| 29 | TAOK1 | 0.94793329 |
| 30 | MAP3K14 | 0.89664930 |
| 31 | SRPK1 | 0.89183851 |
| 32 | TBK1 | 0.85156894 |
| 33 | BRAF | 0.82942994 |
| 34 | CDC7 | 0.78483713 |
| 35 | PIK3CG | 0.78374459 |
| 36 | NME2 | 0.77130410 |
| 37 | MAP3K8 | 0.76849826 |
| 38 | CDK7 | 0.76820540 |
| 39 | IRAK3 | 0.76615515 |
| 40 | DYRK1B | 0.74448587 |
| 41 | ATR | 0.73505569 |
| 42 | TESK1 | 0.73238387 |
| 43 | GRK6 | 0.71967085 |
| 44 | SYK | 0.70981801 |
| 45 | NUAK1 | 0.70789271 |
| 46 | PRKCQ | 0.69837655 |
| 47 | MATK | 0.65429514 |
| 48 | MARK2 | 0.62747570 |
| 49 | IKBKB | 0.62688554 |
| 50 | BUB1 | 0.62527021 |
| 51 | ITK | 0.61451365 |
| 52 | CDK4 | 0.60747136 |
| 53 | JAK3 | 0.60608091 |
| 54 | BTK | 0.60353202 |
| 55 | CSF1R | 0.57683567 |
| 56 | DYRK3 | 0.57077072 |
| 57 | VRK1 | 0.56005888 |
| 58 | MAP3K11 | 0.54294724 |
| 59 | HIPK2 | 0.54262226 |
| 60 | DYRK2 | 0.53357650 |
| 61 | RPS6KL1 | 0.51174842 |
| 62 | RPS6KC1 | 0.51174842 |
| 63 | IKBKE | 0.48973240 |
| 64 | MAP2K3 | 0.48091209 |
| 65 | ICK | 0.46744765 |
| 66 | RPS6KA4 | 0.45607969 |
| 67 | LYN | 0.43696405 |
| 68 | RPS6KA6 | 0.40779598 |
| 69 | DAPK1 | 0.39719740 |
| 70 | MAPK11 | 0.39572711 |
| 71 | RAF1 | 0.38645831 |
| 72 | CDK9 | 0.38186773 |
| 73 | MAPKAPK3 | 0.37904435 |
| 74 | LCK | 0.37002954 |
| 75 | CAMK1D | 0.36697112 |
| 76 | PRKCI | 0.36602402 |
| 77 | MAP2K2 | 0.35512724 |
| 78 | RPS6KA5 | 0.34512027 |
| 79 | WNK4 | 0.32961487 |
| 80 | EIF2AK1 | 0.31781648 |
| 81 | PRKD1 | 0.30733055 |
| 82 | PIM1 | 0.30496122 |
| 83 | RPS6KB2 | 0.29716104 |
| 84 | WEE1 | 0.29401070 |
| 85 | STK10 | 0.28776912 |
| 86 | HCK | 0.28301758 |
| 87 | BRSK1 | 0.27800937 |
| 88 | AURKB | 0.27381094 |
| 89 | IRAK4 | 0.26820050 |
| 90 | PRKCH | 0.26316810 |
| 91 | CAMK1G | 0.25305872 |
| 92 | PLK1 | 0.23395563 |
| 93 | TAOK2 | 0.22677042 |
| 94 | LMTK2 | 0.22585287 |
| 95 | ABL2 | 0.22481939 |
| 96 | CHEK1 | 0.21870033 |
| 97 | CSNK2A1 | 0.21617884 |
| 98 | BRSK2 | 0.21212956 |
| 99 | CDK2 | 0.20975037 |
| 100 | CDK19 | 0.20830177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Base excision repair_Homo sapiens_hsa03410 | 4.08866063 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.36540168 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.85161612 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.68777731 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.64429704 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.64407605 |
| 7 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.51061688 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.46066425 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.41304602 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.33059710 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.28887543 |
| 12 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.17621613 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.16339143 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.11145186 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92449684 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 1.73601827 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.73079959 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67205634 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.60117763 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.59560288 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.58836080 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53271262 |
| 23 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.50206477 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46609395 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44607121 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.39246938 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.34083110 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33172429 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31832929 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.30139927 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28543990 |
| 32 | RNA polymerase_Homo sapiens_hsa03020 | 1.25676043 |
| 33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25508223 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19734837 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.17315669 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.13911051 |
| 37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.13741878 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.09747041 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08978237 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03468265 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03051548 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.02581141 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01356851 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00048907 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95334284 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92176775 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92166860 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.89638232 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88455199 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84918996 |
| 51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83750163 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82228568 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81926082 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 0.81624456 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76273078 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75265695 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73072508 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.72146403 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.69262094 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68954051 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.66047132 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65167772 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63196362 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.60384481 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.59893265 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59664102 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58948611 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.58869894 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58600729 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.57255298 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56901156 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55400604 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52636155 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51764911 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50974428 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.48547267 |
| 77 | Influenza A_Homo sapiens_hsa05164 | 0.47876322 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46532120 |
| 79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46071620 |
| 80 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44636134 |
| 81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44613227 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43364200 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42354116 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42336769 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42190778 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41622693 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40153281 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37845712 |
| 89 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36349437 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36305585 |
| 91 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35972155 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35960301 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34784001 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34755956 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33799184 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33793577 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32178139 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29788199 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26064521 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24820684 |

